• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物信息学整合与m6A基因在非酒精性脂肪性肝病中的作用鉴定

Integration of bioinformatics and identification of the role of m6A genes in NAFLD.

作者信息

Ma Jianguo, Xu Rongyi, Li Renlin, Fu Yangyang, Xu Jing, Zhou Lei, Qi Yan

机构信息

The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, China.

College of Acupuncture and Massage, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, China.

出版信息

PLoS One. 2025 May 28;20(5):e0321757. doi: 10.1371/journal.pone.0321757. eCollection 2025.

DOI:10.1371/journal.pone.0321757
PMID:40435202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12119021/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is prevalent worldwide and seriously affects health. M6A methylation is crucial in its pathogenesis. In this study, a thorough analysis of three gene expression datasets identified nine key differentially expressed genes DEGs associated with m6A methylation in NAFLD that are involved in important biological processes. Subsequently, functional enrichment analysis, weighted gene co-expression network analysis (WGCNA), gene set variation analysis (GSVA) and immune infiltration analysis were conducted to explore the molecular mechanism and gene expression patterns. The LASSO risk model contains a total of 5 m6A-related differentially expressed genes (m6A-RDEGs)(RBM15, IGF2BP2, EIF3B, YTHDC1, WTAP), and the diagnostic model based on these key genes has high accuracy. Among them, YTHDC1 and WTAP are used as prominent biomarkers. In addition, an interaction network between mRNA and miRNA, RNA-binding protein (RBP), transcription factor (TF) and drugs is also constructed. Finally, the animal model of NAFLD was successfully established and validated by RT-qPCR and western blot. This study provides a valuable tool for clinical diagnosis and drives the progress of NAFLD research.

摘要

非酒精性脂肪性肝病(NAFLD)在全球范围内普遍存在,严重影响健康。m6A甲基化在其发病机制中至关重要。在本研究中,对三个基因表达数据集进行了全面分析,确定了九个与NAFLD中m6A甲基化相关的关键差异表达基因(DEGs),这些基因参与重要的生物学过程。随后,进行了功能富集分析、加权基因共表达网络分析(WGCNA)、基因集变异分析(GSVA)和免疫浸润分析,以探索分子机制和基因表达模式。LASSO风险模型共包含5个与m6A相关的差异表达基因(m6A-RDEGs)(RBM15、IGF2BP2、EIF3B、YTHDC1、WTAP),基于这些关键基因的诊断模型具有较高的准确性。其中,YTHDC1和WTAP作为突出的生物标志物。此外,还构建了mRNA与miRNA、RNA结合蛋白(RBP)、转录因子(TF)和药物之间的相互作用网络。最后,通过RT-qPCR和western blot成功建立并验证了NAFLD动物模型。本研究为临床诊断提供了有价值的工具,并推动了NAFLD研究的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/b845050a93b4/pone.0321757.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/26773828c550/pone.0321757.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/1c55ded0dc7a/pone.0321757.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/e9f505f7b6c6/pone.0321757.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/af2f56ce8155/pone.0321757.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/1c6cc469d69d/pone.0321757.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/13cf8368d47f/pone.0321757.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/00df98c07eb9/pone.0321757.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/c728f87adbc6/pone.0321757.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/ca37516ecfeb/pone.0321757.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/71fb099ef04a/pone.0321757.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/b845050a93b4/pone.0321757.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/26773828c550/pone.0321757.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/1c55ded0dc7a/pone.0321757.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/e9f505f7b6c6/pone.0321757.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/af2f56ce8155/pone.0321757.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/1c6cc469d69d/pone.0321757.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/13cf8368d47f/pone.0321757.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/00df98c07eb9/pone.0321757.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/c728f87adbc6/pone.0321757.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/ca37516ecfeb/pone.0321757.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/71fb099ef04a/pone.0321757.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/12119021/b845050a93b4/pone.0321757.g011.jpg

相似文献

1
Integration of bioinformatics and identification of the role of m6A genes in NAFLD.生物信息学整合与m6A基因在非酒精性脂肪性肝病中的作用鉴定
PLoS One. 2025 May 28;20(5):e0321757. doi: 10.1371/journal.pone.0321757. eCollection 2025.
2
Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.通过加权基因共表达网络分析(WGCNA)和套索回归(LASSO)鉴定并验证了慢性阻塞性肺疾病(COPD)合并非酒精性脂肪性肝炎(NASH)的免疫相关诊断指标和靶向治疗方法。
Front Immunol. 2025 Feb 28;16:1514422. doi: 10.3389/fimmu.2025.1514422. eCollection 2025.
3
Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease.分析果糖诱导的非酒精性脂肪肝病中 N6-甲基腺苷甲基化修饰。
Front Endocrinol (Lausanne). 2021 Dec 7;12:780617. doi: 10.3389/fendo.2021.780617. eCollection 2021.
4
Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure.鉴定非酒精性脂肪性肝病和心力衰竭发病机制关联的共同特征基因和途径。
Front Immunol. 2024 Sep 16;15:1424308. doi: 10.3389/fimmu.2024.1424308. eCollection 2024.
5
Screening of key genes related to M6A methylation in patients with heart failure.心力衰竭患者中与 M6A 甲基化相关的关键基因筛选。
BMC Cardiovasc Disord. 2024 Oct 16;24(1):565. doi: 10.1186/s12872-024-04228-9.
6
Identification and verification of biomarkers associated with arachidonic acid metabolism in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中与花生四烯酸代谢相关生物标志物的鉴定与验证
Sci Rep. 2025 Mar 12;15(1):8521. doi: 10.1038/s41598-025-92972-z.
7
m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma.m6A 调节子介导的 RNA 甲基化修饰模式及重症哮喘免疫微环境浸润特征。
J Cell Mol Med. 2021 Nov;25(21):10236-10247. doi: 10.1111/jcmm.16961. Epub 2021 Oct 14.
8
Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.对椎间盘退变亚群分类中 m6A 甲基化调节剂的实验验证和综合分析。
Sci Rep. 2024 Apr 10;14(1):8417. doi: 10.1038/s41598-024-58888-w.
9
Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD.整合分析肝 mRNA 和 miRNA 谱,鉴定 NAFLD 的分子网络和潜在生物标志物。
Sci Rep. 2018 May 16;8(1):7628. doi: 10.1038/s41598-018-25743-8.
10
mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的 mRNA-miRNA-lncRNA 调控网络。
Int J Mol Sci. 2021 Jun 24;22(13):6770. doi: 10.3390/ijms22136770.

本文引用的文献

1
Macrophage exosomes mediate palmitic acid-induced metainflammation by transferring miR-3064-5p to target IκBα and activate NF-κB signaling.巨噬细胞外泌体通过将miR-3064-5p转移至靶标IκBα并激活NF-κB信号传导来介导棕榈酸诱导的代谢性炎症。
J Adv Res. 2025 May;71:501-519. doi: 10.1016/j.jare.2024.06.024. Epub 2024 Jul 2.
2
METTL14 downregulation drives S100A4 monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression.METTL14 下调通过 MyD88/NF-κB 通路驱动 S100A4 单核细胞衍生的巨噬细胞促进 MAFLD 进展。
Signal Transduct Target Ther. 2024 Apr 17;9(1):91. doi: 10.1038/s41392-024-01797-1.
3
YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.
YTHDC1 受 YY1/HDAC2 复合物下调,并通过靶向 ANXA1-MAPK 通路控制 ccRCC 对舒尼替尼的敏感性。
J Exp Clin Cancer Res. 2022 Aug 17;41(1):250. doi: 10.1186/s13046-022-02460-9.
4
A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies.一个定量系统药理学平台揭示了非酒精性脂肪性肝病的病理生理状态和靶向策略。
Metabolites. 2022 Jun 7;12(6):528. doi: 10.3390/metabo12060528.
5
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals.全球代谢相关性脂肪性肝病的流行情况及临床特征:一项纳入 10739607 人的荟萃分析和系统综述。
J Clin Endocrinol Metab. 2022 Aug 18;107(9):2691-2700. doi: 10.1210/clinem/dgac321.
6
2,2',4,4'-Tetrabromodiphenyl Ether (PBDE 47) Selectively Stimulates Proatherogenic PPARγ Signatures in Human THP-1 Macrophages to Contribute to Foam Cell Formation.四溴二苯醚(PBDE-47)选择性地刺激人 THP-1 巨噬细胞中的前动脉粥样硬化性 PPARγ 特征,有助于泡沫细胞的形成。
Chem Res Toxicol. 2022 Jun 20;35(6):1023-1035. doi: 10.1021/acs.chemrestox.2c00043. Epub 2022 May 16.
7
METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.METTL3 通过调节 EGF/RAD51 轴促进乳腺癌同源重组修复并调节化疗反应。
Elife. 2022 May 3;11:e75231. doi: 10.7554/eLife.75231.
8
Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.RBM15的表观遗传激活通过调节CXCL11的m6A修饰促进肾透明细胞癌的生长、转移和巨噬细胞浸润。
Free Radic Biol Med. 2022 May 1;184:135-147. doi: 10.1016/j.freeradbiomed.2022.03.031. Epub 2022 Apr 2.
9
Global multi-stakeholder endorsement of the MAFLD definition.全球多方利益相关者对MAFLD定义的认可。
Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3.
10
Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.长链非编码 RNA N6-甲基腺苷修饰在系统性红斑狼疮中的作用。
Mol Immunol. 2022 Mar;143:77-84. doi: 10.1016/j.molimm.2022.01.006. Epub 2022 Jan 17.